Literature DB >> 4034287

Relation of age, race, and allotype to immunoglobulin subclass concentrations.

P G Shackelford, D M Granoff, M H Nahm, M G Scott, B Suarez, J P Pandey, S J Nelson.   

Abstract

Concentrations of IgG1, IgG2, and total IgG were measured by a solid phase radioimmunoassay in sera from 36 healthy adults and 114 healthy children. As expected, IgG2 and total IgG had a positive correlation with age in children. In addition to age, several other factors were associated with significant differences in serum subclass concentrations. Female children had higher concentrations of IgG1 than males, and black subjects had significantly higher concentrations of IgG1, IgG2, and total IgG than whites. Although Km(1) and Gm(23) immunoglobulin allotypes had no relation to subclass concentrations when tested as single factors, the Km(1) allotype interacted significantly with race so that Km(1)-positive black children had higher IgG2 concentrations than other subjects. Our findings may explain, in part, recent observations of an association of the Km(1) allotype with altered immune responses of blacks to certain vaccines containing bacterial polysaccharides. In addition, our data indicate the need to control factors such as sex, race, and allotype in studies of subclass concentrations or immune responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4034287     DOI: 10.1203/00006450-198508000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis.

Authors:  J I Choi; M H Ha; J H Kim; S J Kim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Percentile ranges for serum IgG subclass concentrations in healthy Chinese children.

Authors:  Y L Lau; B M Jones; K W Ng; C Y Yeung
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

3.  Molecular analysis of the subgingival microbiota in health and disease.

Authors:  Ruth G Ledder; Peter Gilbert; Sharon A Huws; Leon Aarons; Martin P Ashley; Peter S Hull; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

4.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

5.  Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis.

Authors:  K Sugita; M Ishii; J Takanashi; H Niimi; N Yuki
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

6.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.

Authors:  M T Jelonek; S J Chang; C Y Chiu; M K Park; M H Nahm; J I Ward
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.

Authors:  G Zackrisson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

9.  IgG subclass deficiency in asthma.

Authors:  B G Loftus; J F Price; A Lobo-Yeo; D Vergani
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

10.  Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts.

Authors:  Iana H Haralambieva; Hannah M Salk; Nathaniel D Lambert; Inna G Ovsyannikova; Richard B Kennedy; Nathaniel D Warner; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2014-02-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.